Literature DB >> 21212694

Effects of maternal magnesium sulfate administration on intestinal blood flow velocity in preterm neonates.

Thomas Havranek1, Terri L Ashmeade, Maria Afanador, Jane D Carver.   

Abstract

BACKGROUND: Antenatal MgSO4 administration is used extensively as a tocolytic agent and to treat preeclampsia. Various effects on the fetus and newborn have been reported, and MgSO4 has well-documented vasoactive effects.
OBJECTIVE: To determine if antenatal MgSO4 administration affects intestinal blood flow velocity in newborn preterm infants.
METHODS: Peak, mean and end-diastolic velocities in the superior mesenteric artery were measured on day 1 of life. Maternal medical records were reviewed to identify infants whose mothers had been administered MgSO4 for preterm labor or preeclampsia within 24 h of delivery. RESULT: Fifty-six infants were studied: 27 were exposed and 29 were not exposed to antenatal MgSO4. Mean birth weight (1,371 ± 349 and 1,401 ± 469 g, respectively), gestational age (29.7 ± 2.0 and 30.0 ± 2.9 weeks, respectively) and infant hemodynamic and clinical variables (other than clinical indication for antenatal MgSO4 administration) were similar between groups. There were no significant differences between the exposed and unexposed groups in intestinal blood flow velocities. For the exposed group, however, there was a significant negative correlation between mean velocity and the number of hours from birth to the time superior mesenteric artery blood flow velocity measurements were made (p = 0.002); there was no correlation for the unexposed group (p = 0.852).
CONCLUSION: Group mean values indicate that antenatal exposure to MgSO4 does not significantly affect intestinal blood flow velocity in newborn preterm infants. However, the significant negative relationship between mean blood flow velocity and time from birth to blood flow velocity measurement in exposed infants suggests that there may be measurable effects of MgSO4 exposure within the hours immediately after birth. Trials that prospectively evaluate the development of intestinal blood flow velocities are needed to further clarify potential effects of antenatal MgSO4 on the gastrointestinal tract of preterm infants.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212694     DOI: 10.1159/000319049

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  9 in total

1.  Lack of Evidence for Time or Dose Relationship between Antenatal Magnesium Sulfate and Intestinal Injury in Extremely Preterm Neonates.

Authors:  Michel Mikhael; Cheryl Bronson; Lishi Zhang; Mark Curran; Helen Rodriguez; Kushal Y Bhakta
Journal:  Neonatology       Date:  2019-04-09       Impact factor: 4.035

2.  Antenatal magnesium sulfate and spontaneous intestinal perforation in infants less than 25 weeks gestation.

Authors:  B N Rattray; D M Kraus; L R Drinker; R N Goldberg; D T Tanaka; C M Cotten
Journal:  J Perinatol       Date:  2014-06-05       Impact factor: 2.521

3.  Magnesium sulphate and cardiovascular and cerebrovascular adaptations to asphyxia in preterm fetal sheep.

Authors:  Robert Galinsky; Joanne O Davidson; Paul P Drury; Guido Wassink; Christopher A Lear; Lotte G van den Heuij; Alistair J Gunn; Laura Bennet
Journal:  J Physiol       Date:  2015-07-08       Impact factor: 5.182

4.  Effects of Maternal Magnesium Sulfate Treatment on Neonatal Feeding Tolerance.

Authors:  Meghan K Belden; Sarah Gnadt; Ann Ebert
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Mar-Apr

5.  Increased Risk of Meconium-Related Ileus in Extremely Premature Infants Exposed to Antenatal Magnesium Sulfate.

Authors:  Se In Sung; So Yoon Ahn; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Misun Yang; Yun Sil Chang; Won Soon Park
Journal:  Neonatology       Date:  2022-01-11       Impact factor: 4.035

6.  Neonatal Effects of Maternal Magnesium Sulphate in Late Preterm and Term Pregnancies.

Authors:  Arun Ambadkar; Madhva Prasad; Anahita R Chauhan
Journal:  J Obstet Gynaecol India       Date:  2017-11-15

7.  Antenatal magnesium sulphate and adverse neonatal outcomes: A systematic review and meta-analysis.

Authors:  Emily Shepherd; Rehana A Salam; Deepak Manhas; Anne Synnes; Philippa Middleton; Maria Makrides; Caroline A Crowther
Journal:  PLoS Med       Date:  2019-12-06       Impact factor: 11.069

8.  Association of in utero magnesium exposure and spontaneous intestinal perforations in extremely low birth weight infants.

Authors:  L C Downey; C M Cotten; C P Hornik; M M Laughon; V N Tolia; R H Clark; P B Smith
Journal:  J Perinatol       Date:  2017-01-26       Impact factor: 3.225

9.  Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation.

Authors:  Ji Young Hong; Jee Youn Hong; Yun-Sun Choi; Yoo-Min Kim; Ji-Hee Sung; Suk-Joo Choi; Soo-Young Oh; Cheong-Rae Roh; Hye Seon Kim; Se In Sung; So Yoon Ahn; Yun Sil Chang; Won Soon Park
Journal:  Sci Rep       Date:  2020-07-30       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.